Dong Y Y, Zheng X W, Mijiti Maierhaba, Tian R, Guo Q B, Wu Y Y, Gao W, Wen S X
Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, Department of Otolaryngology Head and Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, China.
Department of Otolaryngology Head and Neck Surgery, Longgang Otolaryngology Hospital, Shenzhen 518172, China.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Mar 7;58(3):240-249. doi: 10.3760/cma.j.cn115330-20220621-00364.
To investigate the relationship between the long-non-coding RNA expression and the clinicopathological parameters of head and neck squamous cell carcinoma (HNSCC) and the biological function of in HNSCC cells. The expression level of in the HNSCC was analyzed using transcriptome sequencing data from TCGA (The Cancer Genome Atlas) database, and the expressions of in laryngeal squamous cell carcinoma tissues (LSCC) of 27 patients in the First Hospital of Shanxi Medical University were detected by transcriptome sequencing. The expression levels of in human embryonic lung diploid cells 2BS, HNSCC cell lines FD-LSC-1, CAL-27 and Detroit562 were determined by real-time quantitative polymerase chain reaction (qPCR). RNAi (RNA interference) was used for knockdown in HNSCC cell lines, and the changes of malignant phenotype in the tumor cells after knockdown were examined by cell counting kit-8 (CCK-8), colony formation, flow cytometry, transwell invasion and migration assays. Bioinformatics analysis was performed to construct a -centered competing endogenous RNA (ceRNA) regulatory network, and GO (Gene Ontology) enrichment analysis was performed. Statistical analysis and graphing were performed using SPSS 25.0 software and GraphPad Prism 6 software. Mean levels in HNSCC tissues and TCGA database were higher than that in normal control tissues, but with no significantly statistical difference (0.522). expression levels were positively correlated with cervical lymph node metastasis and pathological grade in patients with HNSCC, with higher expression in male patients than in female patients (0.05). Transcriptome sequencing analysis showed that mean expression level of in LSCC tissues of 27 patients was significantly higher than that in the paired adjacent normal mucosa tissues (1.56, 0.036). expression was significantly upregulated in HNSCC cell lines FD-LSC-1, CAL-27 and Detroit562 (-values of -12.17, -23.26 and -388.57, respectively; all 0.001). Knockdown of by transfecting si--1 and si--2 inhibited HNSCC cell proliferation (-values of 8.95 and 4.84, 2.70 and 5.55, 2.02 and 3.70, respectively), colony formation (-values of 6.66 and 6.17, 7.38 and 11.65, 4.90 and 5.79, respectively), migration (-values of 8.21 and 7.19, 5.76 and 6.46, 6.28 and 9.92, respectively) and invasion abilities (-values of 9.29 and 10.25, 11.30 and 11.36, 8.02 and 8.66, respectively), but promoting apoptosis in cell lines FD-LSC-1 and CAL-27 (-values of -2.21 and -5.83, -3.05 and -5.25 respectively) (all -values<0.05). The -centered ceRNA network consists of 10 downregulated microRNA and 647 upregulated mRNA nodes. GO analysis results indicated that -regulated mRNAs were enriched in 22 biological processes, 32 molecular functions, and 12 cellular components. High level of is associated with the malignant progression of HNSCC. promotes the proliferation, migration, invasion, and antagonizes apoptosis of HNSCC cells, which serves as a potential molecular marker in HNSCC.
探讨长链非编码RNA表达与头颈部鳞状细胞癌(HNSCC)临床病理参数之间的关系以及其在HNSCC细胞中的生物学功能。利用来自TCGA(癌症基因组图谱)数据库的转录组测序数据分析HNSCC中该长链非编码RNA的表达水平,并通过转录组测序检测山西医科大学第一医院27例喉鳞状细胞癌组织(LSCC)中该长链非编码RNA的表达。采用实时定量聚合酶链反应(qPCR)测定人胚肺二倍体细胞2BS、HNSCC细胞系FD-LSC-1、CAL-27和Detroit562中该长链非编码RNA的表达水平。在HNSCC细胞系中利用RNA干扰(RNAi)敲低该长链非编码RNA,通过细胞计数试剂盒-8(CCK-8)、集落形成、流式细胞术、Transwell侵袭和迁移实验检测敲低后肿瘤细胞恶性表型的变化。进行生物信息学分析构建以该长链非编码RNA为中心的竞争性内源RNA(ceRNA)调控网络,并进行基因本体(GO)富集分析。使用SPSS 25.0软件和GraphPad Prism 6软件进行统计分析和绘图。HNSCC组织和TCGA数据库中的该长链非编码RNA平均水平高于正常对照组织,但无显著统计学差异(0.522)。该长链非编码RNA表达水平与HNSCC患者的颈部淋巴结转移和病理分级呈正相关,男性患者中的表达高于女性患者(0.05)。转录组测序分析显示,27例患者LSCC组织中该长链非编码RNA的平均表达水平显著高于配对的相邻正常黏膜组织(1.56,0.036)。该长链非编码RNA在HNSCC细胞系FD-LSC-1、CAL-27和Detroit562中显著上调(-值分别为-12.17、-23.26和-388.57;均P<0.001)。转染si-该长链非编码RNA-1和si-该长链非编码RNA-2敲低该长链非编码RNA抑制了HNSCC细胞增殖(-值分别为8.95和4.84、2.70和5.55、2.02和3.70)、集落形成(-值分别为6.66和6.17、7.38和11.65、4.90和5.79)、迁移(-值分别为8.21和7.19、5.76和6.46、6.28和9.92)和侵袭能力(-值分别为9.29和10.25、11.30和11.36、8.02和8.66),但促进了细胞系FD-LSC-1和CAL-27中的细胞凋亡(-值分别为-2.21和-5.83、-3.05和-5.25)(所有P值<0.05)。以该长链非编码RNA为中心的ceRNA网络由10个下调的微小RNA和647个上调的mRNA节点组成。GO分析结果表明,该长链非编码RNA调控的mRNA在22个生物学过程、32个分子功能和12个细胞成分中富集。该长链非编码RNA的高水平与HNSCC的恶性进展相关。该长链非编码RNA促进HNSCC细胞的增殖、迁移、侵袭并拮抗细胞凋亡,其可作为HNSCC的潜在分子标志物。